ArticlePatient preference and adherence2013
What are the barriers faced by patients using insulin? A qualitative study of Malaysian health care professionals' views.
Article in Patient preference and adherence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 35 citations in OpenAlex.
- Feasibility of continuous glucose monitoring in an acute geriatric unit - the GLYCOGER study.BMC geriatrics · 2026Observational
- Metaphoric medicine: A retrospective clinical audit of glycaemic outcomes associated with an analogy-based consultation framework for insulin-treated type 2 diabetes mellitus.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2026Article
- Risk of insulin initiation with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A real-world claims database study in Japan.Diabetes, obesity & metabolism · 2025Article
- Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.World journal of diabetes · 2024Review
- Development and Validation of USM-Insulin Adherence Module for Patients with Type 2 Diabetes Mellitus.The Malaysian journal of medical sciences : MJMS · 2024Article
- Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review.Therapeutic advances in endocrinology and metabolism · 2024Review
- TheAnnals of medicine · 2022Article
- Barriers and facilitators to insulin treatment: a phenomenological inquiry.Journal of pharmaceutical policy and practice · 2022Article
- Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.Public health reviews · 2022Article
- Which Aspect of Patient-Provider Relationship Affects Acceptance and Adherence of Insulin Therapy in Type 2 Diabetes Mellitus? A Qualitative Study in Primary Care.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022Article
- A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes.Diabetes/metabolism research and reviews · 2021Review
- Article
- Article
- Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis.BMC family practice · 2018Review
- Review of insulin-associated hypoglycemia and its impact on the management of diabetes in Southeast Asian countries.Journal of diabetes investigation · 2017Review
- [Perception of insulin therapy in uncontrolled patients with type 2 diabetes mellitus].Atencion primaria · 2016Article
- Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.Diabetes, obesity & metabolism · 2016Article
- A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia.The Australasian medical journal · 2015Article
- How to engage type-2 diabetic patients in their own health management: implications for clinical practice.BMC public health · 2014Article
- Mixed feelings about the diagnosis of type 2 diabetes mellitus: a consequence of adjusting to health related quality of life.Collegium antropologicum · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with type 2 diabetes often require insulin as the disease progresses. However, health care professionals frequently encounter challenges when managing patients who require insulin therapy. Understanding how health care professionals perceive the barriers faced by patients on insulin will facilitate care and treatment strategies.
objectiveThis study explores the views of Malaysian health care professionals on the barriers faced by patients using insulin.
methodsSemi-structured qualitative interviews and focus group discussions were conducted with health care professionals involved in diabetes care using insulin. Forty-one health care professionals participated in the study, consisting of primary care doctors (n = 20), family medicine specialists (n = 10), government policymakers (n = 5), diabetes educators (n = 3), endocrinologists (n = 2), and one pharmacist. We used a topic guide to facilitate the interviews, which were audio-recorded, transcribed verbatim, and analyzed using a thematic approach.
resultsFIVE THEMES WERE IDENTIFIED AS BARRIERS: side effects, patient education, negative perceptions, blood glucose monitoring, and patient adherence to treatment and follow-up. Patients perceive that insulin therapy causes numerous negative side effects. There is a lack of patient education on proper glucose monitoring and how to optimize insulin therapy. Cost of treatment and patient ignorance are highlighted when discussing patient self-monitoring of blood glucose. Finally, health care professionals identified a lack of a follow-up system, especially for patients who do not keep to regular appointments.
conclusionThis study identifies five substantial barriers to optimizing insulin therapy. Health care professionals who successfully identify and address these issues will empower patients to achieve effective self-management. System barriers require government agency in establishing insulin follow-up programs, multidisciplinary diabetes care teams, and subsidies for glucometers and test strips.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.